-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/asthma-pharmacologic-treatment_research-protocol.pdf
December 27, 2016 - The SOE approach incorporates five key domains: study
limitations, directness, consistency, precision … Additional domains (plausible confounding, dose-response, and magnitude of
effect) will be considered … Asthma control is determined by
assessing the domains of impairment (patient self-reported symptoms, … Bronchial hyperreactivity/
6. Reactive airway disease.mp.
7. 1 or 2 or 3 or 4 or 5 or 6
8. … Bronchial hyperreactivity/
6. Reactive airway disease.mp.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/celiac-disease_research-protocol.pdf
June 12, 2014 - We will discuss their methods of evaluating the domains described below. … Table 6. … PMID: 23609613.
6. Hill ID, Dirks MH, Liptak GS, et al. … Evid Rep Technol Assess
(Summ). 2004 Jun(104):1-6. PMID: 15346868.
9. … Clin Gastroenterol. 2013;47(2):121-6.
11. Chang SM, Matchar DB, al. e.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
March 19, 2018 - The specific domains which
contributed to the downgrading of
all outcomes, organized per KQ,
appear … Further description
as to the domains that led to
downgrading a given outcome are
provided in the … The five
contributing domains include risk
of bias, consistency, directness,
precision and publication … ROB was taken into
account when SOE was graded,
as one of the domains. … ROB was taken into account when
SOE was graded, as one of the
domains.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bimp-protocol.pdf
September 27, 2022 - Third wave CBT
• Acceptance and commitment therapy
6. … study
and assign a risk of bias rating of “high,” “some concerns,” and “low” for each of the above
domains … The primary
domains assessed include risk of bias, directness, consistency, precision, and reporting … Below, we discuss the primary domains and how we will assess them:
Risk of bias (see the above section … PMID: 30600979.
6. American Headache Society.
-
effectivehealthcare-admin.ahrq.gov/products/fecal-incontinence/clinician
December 01, 2019 - Conclusions
Evidence to support any fecal incontinence treatments in adults beyond 3 to 6 months is … ; unapproved by the FDA for fecal incontinence treatment) reduced fecal incontinence severity up to 6 … the number of FI episodes over 2 weeks was not significantly different between groups at 3 months or 6 … † The overall evidence grade was assessed based on the ratings for the following domains: study limitations … Other domains that were considered, as appropriate, included dose-response association, plausible confounding
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/infantile-epilepsy-amended-protocol.pdf
March 07, 2021 - For Key Question 3 (harms), we will include single-arm studies as well as controlled
studies.
6. … We will grade the SOE
based on the EPC Methods Guide recommendations.4 The primary domains assessed … The rating will be
based on considering all of the domains listed below. … Below, we discuss the primary domains
and how we will assess them:
Risk of bias (see the above section … PMID: 2304219.
6. Neinstein LS.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/quality-of-life-functional-status-measurement_white-paper.pdf
September 01, 2013 - Finally the economics and decision science
paradigm, like the clinimetric tradition, selects domains … Correlations for domains of the
SF-36 ranged from 0.28 to 0.70; the correlation for EQ-5D scores was … Med Care 1992
Jun;30(6):473-83.
9. Horsman J, Furlong W, Feeny D, et al. … Qual Life Res 2000;9(6):591-601.
54. Brazier J, Roberts J, Tsuchiya A, et al. … Disabil Rehabil 2001 Oct
15;23(15):670-6.
149. Jones CA, Feeny D, Eng K.
-
effectivehealthcare-admin.ahrq.gov/products/meditation/research
December 01, 2019 - Well-Being
Systematic Review
ARCHIVED
Jan 6, … We graded the strength of evidence (SOE) using four domains (risk of bias, precision, directness, and … improvement in anxiety (effect size [ES], 0.40; CI, 0.08 to 0.71 at 8 weeks; ES, 0.22; CI, 0.02 to 0.43 at 3–6 … 0.01 to 0.66 at 8 weeks; ES, 0.23; CI, 0.05 to 0.42 at 3–6 months); and pain (ES, 0.33; CI, 0.03 to 0.62 … Topic Initiated
Oct 17, 2012
Research Protocol
Archived
Jan 6,
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-protocol-amendment.pdf
November 28, 2023 - Bias tool 2.0.21 Risk will be assessed as low, moderate,
8
or high for each of the following domains … will be assessed as low,
moderate, serious, critical, or no information for each of the following domains … ROBINS-E) tool23 as low, moderate, serious, critical,
or no information for each of the following domains … strength of evidence for outcomes for within each comparison will be
evaluated based on five required domains … Sep 6 2003;327(7414):557-60. doi:10.1136/bmj.327.7414.557
28.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amendment.pdf
February 05, 2025 - study
and assign a risk of bias rating of “high,” “some concerns,” or “low” for each of the above
domains … Below, we discuss the primary domains and how we will assess them:
Risk of bias (see the above section … PMID: 36369475.
6. National Survey of Children’s Health. … Mindfulness. 2022;13(2):285-300. doi:
10.1007/s12671-021-01775-6.
32. … GRADE guidelines 6. Rating the quality of evidence--
imprecision.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/ped-mindfulness-protocol-amended.pdf
September 25, 2024 - study
and assign a risk of bias rating of “high,” “some concerns,” or “low” for each of the above
domains … In case they are relevant, additional domains, such as dose-response association and
strength of association … Below, we discuss the primary domains and how we will assess them:
Risk of bias (see the above section … PMID: 36369475.
6. National Survey of Children’s Health. … Mindfulness. 2022;13(2):285-300. doi:
10.1007/s12671-021-01775-6.
32.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
January 01, 2022 - NR + 2.85 mg/d
6 months: 3.05 mg/d + 2,295.5 mg/d vs. … NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … B 0.67 (95% CI 0.44 to 1.02)
6 months: 38% (21/49) vs. 48% (31/52) vs. NR, RR for A vs. … C
6 months: 35% (17/49) vs. 60% (31/52) vs. 36% (20/55), RR 0.58 (95% CI 0.37 to 0.91 for A vs. … C Individual SF-36 domains; Individual depression and anxiety domains for HADS; BPI Pain Severity; EQ
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
January 01, 2022 - NR + 2.85 mg/d
6 months: 3.05 mg/d + 2,295.5 mg/d vs. … NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … B 0.67 (95% CI 0.44 to 1.02)
6 months: 38% (21/49) vs. 48% (31/52) vs. NR, RR for A vs. … C
6 months: 35% (17/49) vs. 60% (31/52) vs. 36% (20/55), RR 0.58 (95% CI 0.37 to 0.91 for A vs. … C Individual SF-36 domains; Individual depression and anxiety domains for HADS; BPI Pain Severity; EQ
-
effectivehealthcare-admin.ahrq.gov/products/fecal-incontinence/research-protocol
December 01, 2019 - percent of residents with severe cognitive impairment have experienced FI. 4 Monthly FI occurs in 6 … Colorectal Dis 2012; Jun;14(6):e297-304. PMID: 22356165.
Glasgow SC, Lowry AC. … Medical care 1992; Jun;30(6):473-83. PMID: 1593914.
Rockwood TH, Church JM, Fleshman JW, et al. … Dis Colon Rectum 2001; Jun;44(6):799-805. PMID: 11391139.
Williams A. … No
Intervention poorly described
6.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
March 01, 2018 - Strength of evidence domains for studies comparing lacosamide with placebo in terms
of quality of life … Strength of evidence domains for studies comparing 8% capsaicin patch with placebo
in terms of pain … Neurology. 1998
Jun;50(6):1842-6. PMID: 9633738.
53. . … J Am Podiatr Med
Assoc. 1991 Jun;81(6):288-93. doi:
10.7547/87507315-81-6-288. … Lancet. 1988 Jan 2-
9;1(8575-6):9-11. PMID: 2891940.
60.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amended.pdf
September 25, 2024 - Below, we discuss the primary domains and how we will assess them:
Risk of bias (see the above section … PMID: 36369475.
6. National Survey of Children’s Health. … Pediatrics. 2016 Dec;138(6) doi: 10.1542/peds.2016-1878.
PMID: 27940701.
13. … Mindfulness. 2022;13(2):285-300. doi:
10.1007/s12671-021-01775-6.
32. … GRADE guidelines 6. Rating the quality of evidence--
imprecision.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/multiple-sclerosis_research-protocol.pdf
December 17, 2013 - literature, using an instrument we develop based upon the Cochrane Risk of Bias tool.11
The seven domains … outcome data, selective reporting, and other sources of bias (i.e., problems not
covered by other domains … to sustained disease progression) within each
comparison will be evaluated based on four required domains … an estimate).16 A fifth domain, reporting bias, will be assessed when
SOE based upon the first four domains … Q Rev Biol.
2011 Dec;86(4):287-321.
6. Daumer M, Neuhaus A, Herbert J, et al.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
July 18, 2011 - the randomized controlled trials and nonrandomized controlled trials.
20
The tool examines six
domains … The overall assessment is based on the responses to individual domains. … If one or
more individual domains are assessed as having a high risk of bias, the overall score will … for Effectiveness and
Comparative Effectiveness Reviews.
29
We will examine the following four domains … Rev Neurol (Paris) 2005;161(6-7):658-60.
17.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hro-protocol.pdf
January 01, 2023 - Prioritization Report
for additional details.1
HROs are organizations that operate in complex, high-hazard domains … When assessing RCTs, we will use the 7
items in the Cochrane Collaboration’s tool that cover the domains … PMID: 37838378.
6. Vogus TJ, Sutcliffe KM, Weick KE. … Crit Care.
2011;15(6):314. PMID: 22188677.
8. Veazie S, Peterson K, Bourne D. … HROs are organizations that operate in complex, high-hazard domains for extended periods without serious
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol.pdf
June 10, 2024 - Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by persistent
symptoms in the domains … will be influenced by whether the interventions are likely to help the
core symptoms of ADHD or other domains … We selected the following domains as key outcomes with input from the
technical expert panel: functional … We will evaluate the following domains:
• Study limitations: The extent to which studies reporting … The strength of
the evidence can be downgraded based on the outlined domains.